Joint Formulary & PAD

Potassium canrenaote - Hypertension

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Injection
Associated Icons :
Restrictions / Comments :

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Potassium canrenaote
Indication :
Hypertension
Group Name :
Keywords :
diuresis, aldosterone antagonist
Brand Names Include :
Important Information :

For use in patients who are unable to have oral spironolactone.

Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0